Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Expensive Performer
1398.2000
-20.70
(
-1.46
%)
NSE
May 09, 2025
15:31 PM
41.92% Gain from 52W Low
Volume:
480.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
24 Dec 2024
1398.20
-1.46%
GLENMARK PHARMACEUTICALS
Accumulate:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 1720 | Upside : 23.0%
Target
Geojit BNP Paribas
Glenmark Pharmaceuticals Ltd. is trading below all available SMAs
More from Glenmark Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - May 09, 2025
The Baseline |
09 May 2025, 04:56PM
Market closes lower, Intellect Design Arena's Q4 net profit surges 93% QoQ to Rs 135.3 crore
Trendlyne Marketwatch |
09 May 2025, 03:56PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020